Runxiang Qiu and associates provided evidence that targeting KIF20A in medulloblastoma leads to premature cell cycle exit and enhanced neuronal differentiation, suppressing tumor growth and proposing a novel anti-proliferative treatment strategy by affecting cell fate determination [34]. Here, KIF20A is linked to neoplasm.